Amneal (AMRX) Fundamental Analysis: Revenue, Earnings & Valuation

4.40 / 10

Netural

Fundamental analysis yields a 4.4/10 score, indicating mixed quality. Strong points include inventory turnover, interest coverage, PB‑ROE, and favorable asset/revenue‑to‑market ratios. Weaknesses are high long‑term debt relative to working capital and modest revenue growth, rendering the stock overall defensive.

Analysis Checks(6/10)

Revenue-MV

Value0.58

Score2/3

Weight25.15%

1M Return4.88%

Total operating revenue (YoY growth rate %)

Value8.05

Score1/3

Weight-1.55%

1M Return-0.38%

Inventory turnover ratio

Value3.13

Score3/3

Weight-3.89%

1M Return-0.93%

Current liabilities / Total liabilities (%)

Value24.01

Score3/3

Weight7.37%

1M Return1.67%

PB-ROE

Value0.05

Score3/3

Weight49.94%

1M Return9.18%

Long-term debt to working capital ratio (%)

Value2.71

Score1/3

Weight-2.66%

1M Return-0.65%

Interest coverage ratio (EBIT / Interest expense) (%)

Value1.58

Score2/3

Weight-4.60%

1M Return-1.17%

Operating revenue (YoY growth rate %)

Value8.05

Score1/3

Weight-1.22%

1M Return-0.30%

Cost of sales ratio (%)

Value63.12

Score2/3

Weight-4.34%

1M Return-1.13%

Asset-MV

Value-0.55

Score1/3

Weight35.82%

1M Return6.31%

Is AMRX undervalued or overvalued?

AMRX scores 4.40/10 on fundamentals and holds a Fair valuation at present. Backed by its 0.00% ROE, 4.24% net margin, 56.27 P/E ratio, 679.94 P/B ratio, and 160.53% earnings growth, these metrics solidify its Netural investment rating.